BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31601405)

  • 1. Microglia as possible therapeutic targets for autism spectrum disorders.
    Andoh M; Ikegaya Y; Koyama R
    Prog Mol Biol Transl Sci; 2019; 167():223-245. PubMed ID: 31601405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia in animal models of autism spectrum disorders.
    Andoh M; Ikegaya Y; Koyama R
    Prog Mol Biol Transl Sci; 2020; 173():239-273. PubMed ID: 32711812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia in the pathogenesis of autism spectrum disorders.
    Koyama R; Ikegaya Y
    Neurosci Res; 2015 Nov; 100():1-5. PubMed ID: 26116891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic elimination by microglia and disturbed higher brain functions.
    Miyanishi K; Sato A; Kihara N; Utsunomiya R; Tanaka J
    Neurochem Int; 2021 Jan; 142():104901. PubMed ID: 33181238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects.
    Kim HJ; Cho MH; Shim WH; Kim JK; Jeon EY; Kim DH; Yoon SY
    Mol Psychiatry; 2017 Nov; 22(11):1576-1584. PubMed ID: 27400854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial
    Meng J; Han L; Zheng N; Wang T; Xu H; Jiang Y; Wang Z; Liu Z; Zheng Q; Zhang X; Luo H; Can D; Lu J; Xu H; Zhang YW
    J Neurosci; 2022 Jun; 42(25):4958-4979. PubMed ID: 35606143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia at the Tripartite Synapse during Postnatal Development: Implications for Autism Spectrum Disorders and Schizophrenia.
    Ferrucci L; Cantando I; Cordella F; Di Angelantonio S; Ragozzino D; Bezzi P
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does microglial dysfunction play a role in autism and Rett syndrome?
    Maezawa I; Calafiore M; Wulff H; Jin LW
    Neuron Glia Biol; 2011 Feb; 7(1):85-97. PubMed ID: 22717189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring.
    Fernández de Cossío L; Guzmán A; van der Veldt S; Luheshi GN
    Brain Behav Immun; 2017 Jul; 63():88-98. PubMed ID: 27697456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Microglia in the Amygdala Are Involved in Anxiety-related Behaviors of a Copy Number Variation Mouse Model of Autism.
    Shigemori T; Sakai A; Takumi T; Itoh Y; Suzuki H
    J Nippon Med Sch; 2015; 82(2):92-9. PubMed ID: 25959200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial Intracellular Ca
    Mizoguchi Y; Monji A
    Front Cell Neurosci; 2017; 11():69. PubMed ID: 28367116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of NRXN-NLGN-SHANK pathway gene variations in the pathogenesis of autism spectrum disorders].
    He L; Liu X; Song Y; Tang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):753-756. PubMed ID: 30298512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
    Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
    Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders.
    Spooren W; Lindemann L; Ghosh A; Santarelli L
    Trends Pharmacol Sci; 2012 Dec; 33(12):669-84. PubMed ID: 23084458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro zinc supplementation alters synaptic deficits caused by autism spectrum disorder-associated Shank2 point mutations in hippocampal neurons.
    Vyas Y; Jung Y; Lee K; Garner CC; Montgomery JM
    Mol Brain; 2021 Jun; 14(1):95. PubMed ID: 34167580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptopathology in autism spectrum disorders: Complex effects of synaptic genes on neural circuits.
    Wang X; Kery R; Xiong Q
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):398-415. PubMed ID: 28986278
    [No Abstract]   [Full Text] [Related]  

  • 17. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.
    Kato TA; Yamauchi Y; Horikawa H; Monji A; Mizoguchi Y; Seki Y; Hayakawa K; Utsumi H; Kanba S
    Curr Med Chem; 2013; 20(3):331-44. PubMed ID: 23157624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-tuning the central nervous system: microglial modelling of cells and synapses.
    Xavier AL; Menezes JR; Goldman SA; Nedergaard M
    Philos Trans R Soc Lond B Biol Sci; 2014 Oct; 369(1654):20130593. PubMed ID: 25225087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia: Synaptic modulator in autism spectrum disorder.
    Hu C; Li H; Li J; Luo X; Hao Y
    Front Psychiatry; 2022; 13():958661. PubMed ID: 36465285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.